Novel role of the serine protease inhibitor elafin in gluten-related disorders. - Wikidata - wikimedia - TriplyDB

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

http://www.wikidata.org/entity/Q34449346

about

Protease inhibition as new therapeutic strategy for GI diseases Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.Intestinal microbiota modulates gluten-induced immunopathology in humanized mice.Recent Advances in Celiac Disease from TTG to Gluten in Pee.Transglutaminase as a therapeutic target for celiac disease.Pathophysiological roles of proteases in gastrointestinal disease.The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.Regulation of intestinal permeability: The role of proteases Update on novel targets and potential treatment avenues in pulmonary hypertension.Fundamentals of Neurogastroenterology: Basic Science.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.A commensal Bifidobacterium longum strain improves gluten-related immunopathology in mice through expression of a serine protease inhibitor.

P2860

Q26747722-7398ACFE-F065-4F07-AEC4-433513A01F8B Q26753101-7842EFA0-79CD-4765-9C47-686E1F79A803 Q28087327-1F77CCAB-BA10-47C8-8417-8790E24409A6 Q28244133-8DD3E1F8-4908-4F35-82F4-77E19043AEBC Q33578069-25FDF56F-6EE5-484E-A452-225966201D82 Q35803031-E9475560-8A4A-4A1B-B235-5E1B81A192F4 Q36755761-52C37795-E312-4409-BFBE-EEB119785BD7 Q38269678-31D9A20B-7139-4666-9A28-05437E25ADD5 Q38678675-D2947191-593A-4AB3-B00B-F720877C3636 Q38955820-4FD7BA96-801E-41B2-A85F-258E2246F80A Q39239228-222840B9-169D-4CC6-BD4D-CF9832B7EB1C Q42784219-FF4688E9-DB8F-419E-AC81-AC0723CE7583 Q50965155-21173CC8-7845-4B01-8E55-E396F7AF72C1 Q54217096-881553C2-4C9A-4538-89E6-9298047B2E08 Q55262976-D90D6D47-C9B0-43EC-8822-1403EA14D3DA

P2860

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

http://www.wikidata.org/entity/Q34449346

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@ast

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@en

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@nl

type

label

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@ast

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@en

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@nl

prefLabel

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@ast

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@en

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@nl

P1433

Q34449346-5163830A-E4DD-4106-A00F-3C57EC6F6012

P1476

Q34449346-818E31DF-EFDB-46E4-8EAA-9329B6675126

P2093

Q34449346-072185E3-48DE-4357-B2CA-12288B85B1C4

Q34449346-1D7928EC-0328-4ED7-BB07-A0F910D325C7

Q34449346-239BC9D8-777D-425F-9C7D-C5FFE21D5500

Q34449346-494C2B2A-9D19-4A29-853C-3DCF768F31F3

Q34449346-5ACD2089-B483-43CB-9A7F-57C3BE3DE414

Q34449346-615CA806-984C-4D88-9025-9871FA8CC168

Q34449346-63CB84FD-9645-4CC3-BED0-AA985BAB7EAA

Q34449346-7628559C-50E8-41F3-A855-74D58401E9F5

Q34449346-8609C05E-6CB4-4C79-8051-5A80F316829D

Q34449346-9F6DC6B4-4B18-42E2-9966-59B70008A5A5

P2860

Q34449346-097F4EE6-DF68-49EF-A677-2DB3CD24D173

Q34449346-09E516F3-0D75-48FE-B235-82DD2245D5FB

Q34449346-0B33941A-E238-440F-B457-CBD218AAC92A

Q34449346-0FF7DCE2-1FCA-4BA7-A4BF-1DD94DE70380

Q34449346-1197F95F-3CB0-4938-9079-5449F7F40208

Q34449346-169ACDC7-4870-495A-B1E9-CCEB73FF631E

Q34449346-1820CB72-FFCC-42C7-8489-7C071087DB7D

Q34449346-348FE3DE-5EE5-4173-94E3-3DE50EAB5728

Q34449346-34FD52ED-548D-4CAB-85DC-3B3F87F372E5

Q34449346-3622439F-0332-4536-8A89-FF34E7A13D9E

P2888

Q34449346-D1698DB2-D8B4-4A3C-ADE0-EC8FD9353635

P304

Q34449346-A10B6B4A-C482-4467-944E-BC3533E9AF00

P31

Q34449346-E7DD9E73-84F3-4A84-87EA-CB30C8584209

P356

Q34449346-F6F9C29E-7235-4220-A81C-2D3597BE0AFF

P407

Q34449346-D44B83C6-7976-4A14-AC1E-AD831A505714

P433

Q34449346-1722A980-AD43-4290-A2A2-1E19B039AF63

P478

Q34449346-20675EB6-6065-4A22-821E-166DBA5A229B

P50

Q34449346-63987C1A-BBA1-4FE9-A68A-10BA38086496

Q34449346-873B8420-D7BD-4B2B-BF7E-320F2C53A063

Q34449346-B46329A2-F4F1-475C-A236-3CC7338F4645

P577

Q34449346-9BDBE71C-D3F5-4BF6-8376-3383C4D97F3A

P5875

Q34449346-9EB4D7AC-F68A-459C-9799-8BA88EEA6979

P6179

Q34449346-C14149C2-8A03-450E-8CB9-59F96B6BD115

P698

Q34449346-62554A18-8DF2-46CC-A548-A8F18F5B77B5

P932

Q34449346-8B67227A-0B51-4B3F-9815-065752D5A621

P356

P1433

The American Journal of Gastroenterology

P1476

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

@en

P2093

Daniel Sinclair

http://www.w3.org/2001/XMLSchema#string

Elena F Verdu

http://www.w3.org/2001/XMLSchema#string

Heather J Galipeau

http://www.w3.org/2001/XMLSchema#string

Ines Pinto-Sanchez

http://www.w3.org/2001/XMLSchema#string

Jane M Natividad

http://www.w3.org/2001/XMLSchema#string

Jean Christophe Leroux

http://www.w3.org/2001/XMLSchema#string

Jennifer Jury

http://www.w3.org/2001/XMLSchema#string

Jessica D Schulz

http://www.w3.org/2001/XMLSchema#string

Joseph A Murray

http://www.w3.org/2001/XMLSchema#string

Julio C Bai

http://www.w3.org/2001/XMLSchema#string

P2860

The Oslo definitions for coeliac disease and related terms

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens

Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity

Role of transglutaminase 2 in celiac disease pathogenesis

Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis

Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate

Activation and inhibition of transglutaminase 2 in mice

The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope

Structural basis for gluten intolerance in celiac sprue

Kinetics of the inhibition of proteinase 3 by elafin.

P2888

P304

748-756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJG.2014.48

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Paul Motta

Nathalie Vergnolle

Edgardo Smecuol

P577

2014-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261444392

http://www.w3.org/2001/XMLSchema#string

P6179

1016285706

http://www.w3.org/2001/XMLSchema#string

P698

24710505

http://www.w3.org/2001/XMLSchema#string

P932

4219532

http://www.w3.org/2001/XMLSchema#string